Advertisement

Next Stop for Fatty Acid Amide Hydrolase Inhibitors, the Clinic?

  • Daniele Piomelli
    Correspondence
    Address correspondence to Daniele Piomelli, Ph.D., Department of Anatomy and Neurobiology, 3101 Gillespie Neuroscience Research Facility, University of California, Irvine, CA 92697-4625.
    Affiliations
    Department of Anatomy and Neurobiology, University of California, Irvine, California
    Search for articles by this author
      SEE CORRESPONDING ARTICLE ON PAGE 538
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Novacek J.
        • Raskin R.
        • Hogan R.
        Why do adolescents use drugs? Age, sex, and user differences.
        J Youth Adolesc. 1991; 20: 475-492
        • Fabre L.F.
        • McLendon D.
        The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety.
        J Clin Pharmacol. 1981; 21: 377S-382S
        • Jetly R.
        • Heber A.
        • Fraser G.
        • Boisvert D.
        The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study.
        Psychoneuroendocrinology. 2015; 51: 585-588
        • Rabinak C.A.
        • Angstadt M.
        • Sripada C.S.
        • Abelson J.L.
        • Liberzon I.
        • Milad M.R.
        • Phan K.L.
        Cannabinoid facilitation of fear extinction memory recall in humans.
        Neuropharmacology. 2013; 64: 396-402
        • Black N.
        • Stockings E.
        • Campbell G.
        • Tran L.T.
        • Zagic D.
        • Hall W.D.
        • et al.
        Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: A systematic review and meta-analysis.
        Lancet Psychiatry. 2019; 6: 995-1010
        • Patel S.
        • Hill M.N.
        • Cheer J.F.
        • Wotjak C.T.
        • Holmes A.
        The endocannabinoid system as a target for novel anxiolytic drugs.
        Neurosci Biobehav Rev. 2017; 76: 56-66
        • Chiang K.P.
        • Gerber A.L.
        • Sipe J.C.
        • Cravatt B.F.
        Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: Evidence for a link between defects in the endocannabinoid system and problem drug use.
        Hum Mol Genet. 2004; 13: 2113-2119
        • Minkov M.
        • Bond M.H.
        A genetic component to national differences in happiness.
        Journal of Happiness Studies. 2017; 18: 321-340
        • Spagnolo P.A.
        • Ramchandani V.A.
        • Schwandt M.L.
        • Kwako L.E.
        • George D.T.
        • Mayo L.M.
        • et al.
        FAAH gene variation moderates stress response and symptom severity in patients with posttraumatic stress disorder and comorbid alcohol dependence.
        Alcohol Clin Exp Res. 2016; 40: 2426-2434
        • Mayo L.M.
        • Asratian A.
        • Lindé J.
        • Morena M.
        • Haataja R.
        • Hammar V.
        • et al.
        Elevated anandamide, enhanced recall of fear extinction, and attenuated stress responses following inhibition of fatty acid amide hydrolase: A randomized, controlled experimental medicine trial.
        Biol Psychiatry. 2020; 87: 538-547

      Linked Article